Evidence map›Paper›PMID 32718103›Full record

ArticleInternational journal of molecular sciences2020

Tomatine Displays Antitumor Potential in In Vitro Models of Metastatic Melanoma.

Simona Serratì, Letizia Porcelli, Stefania Guida, Anna Ferretta, Rosa Maria Iacobazzi, Tiziana Cocco, Immacolata Maida, Gabriella Tamasi, Claudio Rossi, Michele Manganelli and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Anti-inflammatory activity of α-tomatineInternational journal of medical sciences · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Bioactive Compounds and Their Impact on Protein Modification in Human Cells.International journal of molecular sciences · 2022
    Article
  10. Review
  11. Anticancer activity of glycoalkaloids fromFrontiers in pharmacology · 2022
    Review
  12. Biomaterial-Assisted Regenerative Medicine.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Simona SerratìExperimental Pharmacology Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
Letizia PorcelliExperimental Pharmacology Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
Stefania GuidaDermatology Unit, University of Modena and Reggio Emilia, 41121 Modena, Italy.ORCID 0000-0002-8221-6694
Anna FerrettaDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, 70124 Bari, Italy.ORCID 0000-0003-2279-9557
Rosa Maria IacobazziExperimental Pharmacology Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
Tiziana CoccoDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, 70124 Bari, Italy.ORCID 0000-0001-7171-3460
Immacolata MaidaDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, 70124 Bari, Italy.
Gabriella TamasiDepartment of Biotechnology Chemistry and Pharmacology, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-6796-8863
Claudio RossiDepartment of Biotechnology Chemistry and Pharmacology, University of Siena, 53100 Siena, Italy.
Michele ManganelliDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, 70124 Bari, Italy.ORCID 0000-0002-8219-0252
Stefania TommasiMolecular Diagnostics and Pharmacogenetics Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
Amalia AzzaritiExperimental Pharmacology Laboratory, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
Gabriella GuidaDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, 70124 Bari, Italy.
Istituto Tumori Bari · ITUniversity of Bari Aldo Moro · ITUniversity of Siena · ITUniversity of Modena and Reggio Emilia · IT

Funding

Italian Ministry of Health and University of Bari, Italy Ricerca Corrente 2018-2020 and Fondi di Ateneo
6 · The paper itself

Abstract

There is a growing interest in the cytotoxic effects of bioactive glycoalkaloids, such as α-tomatine on tumor cells. Here, for the first time, we determine the antitumor potential of tomatine, a mixture of α-tomatine and dehydrotomatine, in metastatic melanoma (MM) cell lines harboring different BRAF and MC1R variants. We performed cytotoxicity experiments and annexin-V/propidium iodide staining to assess the apoptotic/necrotic status of the cells. ER stress and autophagy markers were revealed by Western Blot, whereas antiangiogenic and vascular-disrupting effects were evaluated through a capillary tube formation assay on matrigel and by ELISA kit for VEGF release determination. Cell invasion was determined by a Boyden chamber matrigel assay. Tomatine reduced 50% of cell viability and induced a concentration-dependent increase of apoptotic cells in the range of 0.5-1 μM in terms of α-tomatine. The extent of apoptosis was more than two-fold higher in

Indexed as

ApoptosisMAP Kinase Signaling SystemMelanomaAmino Acid SubstitutionAntineoplastic AgentsCell Line, TumorHumansMutation, MissenseNecrosisNeoplasm InvasivenessNeoplasm MetastasisProto-Oncogene Proteins B-rafTomatineAntineoplastic AgentsBRAF protein, humanProto-Oncogene Proteins B-rafTomatineangiogenesisapoptosisautophagymetastatic melanomatomatine

Identifiers

PMID32718103
PMCPMC7432453
OpenAlexW3045067084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.